Email this article How misunderstanding the principles and limitations of evidence-based medicine may discredit the concept
- Authors: Zorin N.A.1
-
Affiliations:
- Russian Society for Evidence Based Medicine
- Issue: Vol LV, No 2 (2023)
- Pages: 81-89
- Section: Discussions
- URL: https://journals.rcsi.science/1027-4898/article/view/131530
- DOI: https://doi.org/10.17816/nb321817
- ID: 131530
Cite item
Open Access
Access granted
Subscription Access
Abstract
The discussion on the methodological limitations of the quasi- measurement of human feelings and sensations, started by the author in the journal Neurology bulletin, continues. There are a number of reasons for accepting/rejecting and understanding the principles and limitations of clinical epidemiology/evidence-based medicine (EBM) to the point of deliberate distortion. It is shown that the ideas of “freedom” and “creativity” in medicine, are ways of avoiding control and the realization of biopower. A concrete example, the study of the efficacy of antidepressants, shows how it is possible, either unintentionally or intentionally, to obtain a false result without following the principles and tenets of EBM.
Full Text
##article.viewOnOriginalSite##About the authors
Nikita A. Zorin
Russian Society for Evidence Based Medicine
Author for correspondence.
Email: nzorin@inbox.ru
ORCID iD: 0000-0001-7245-216X
SPIN-code: 6352-6095
Scopus Author ID: 56763767500
M.D., Cand. Sci. (Med.)
Russian Federation, MoscowReferences
- Zorin NA. Metodologicheskij samoobman. Imeyut li smysl kvaziizmereniya chelovecheskih chuvstv i oshchushchenij? Nevrologicheskij vestnik. 2018;L(4):19–22. (In Russ.)
- Zorin NA. Eshche raz pro lyubov’ k dokazatel’noj medicine. Nevrologicheskij vestnik. 2019;LI(2):95–100. (In Russ.)
- Zorin NA. Naprasnye nadezhdy, ili pochemu v obozrimom budushchem progressa psihiatrii ne budet. Doklad na konfe-rencii «Diagnosticheskie i terapevticheskie paradoksy sovremennoj psihiatrii», 2 dekabrya 2022 g. Kazan’. https://www.youtube.com/watch?v=75frMHJg-ZU&t=1211s (access date: 13.03.2023). (In Russ.)
- Altenmüller MS, Wingen T, Schulte A. Explaining polarized trust in scientists: A political stereotype-approach. 2022. Nov 23 (preprint). doi: 10.31219/osf.io/tdukb.
- Leskov NS. Zagon. Sobr. soch. v 11 t. T. 9. М.: Gosudarstvennoe izdatel’stvo hudozhestvennoj literatury, 1956–1958. 253 р.
- Zhukov N. Enciklopatiya. Kritika DM. https://encyclopatia.ru/wiki/Kritika_DM (access date: 13.03.2023). (In Russ.)
- Zorin NA. O snose pamyatnikov i pereimenovanii diagnozov. Nezavisimyj psihiatricheskij zhurnal. 2020;(3):70–74. (In Russ.)
- Ioannidis Dzh. Dokazatel’naya medicina zahvachena (lekciya). https://youtu.be/N63skNtYaJw (access date: 13.03.2023). (In Russ.)
- Gøtzsche PC. Does long term use of psychiatric drugs cause more harm than good? BMJ. 2015; 350. doi: 10.1136/bmj.h2435.
- Davtyan EN. Chto izmeryaet shkala depressii Beka? // Psihiatriya i psihofarmakoterapiya. 2013;(2):57–60. (In Russ.)
- Sedok B, Sassmen DzhN, Sedok VE. Rukovodstvo Kaplana i Sedoka po medikamentoznomu lecheniyu v psihiatrii. М.: MEDpress-inform; 2021. 480 р. (In Russ.)
- Davies P, Ijaz Sh, Williams CJ et al. Pharmacological interventions for treatment-resistant depression in adults. Cochrane Database Syst Rev. 2019;12(12):CD010557. doi: 10.1002/14651858.CD010557.pub2.
- Zorin NA. Zachem bol’noj prihodit k vrachu? Glavnyj vrach. 2002;(2):62–65. (In Russ.)
- Davtyan EN. Slovo v zashchitu klinicista (ob ispol’zovanii medicinskij oprosnyh instrumentov v psihiatrii). Psihiatriya i psihofarmakoterapiya. 2014;16(2):59–64. (In Russ.)
- Geddes JR. Suicide prevention trials: Where are we and what do we need? Journal of Psychopharmacology. 2014;28(11):1085–1087.
- Healy D. Antidepressants and suicide: Risk-benefit conundrums. Journal of Psychiatry & Neuroscience: JPN. 2012;37(3):135.
- Moncrieff J. Psychiatric drug promotion and the politics of neoliberalism. British Journal of Psychiatry. 2009;195(3):189–190.
- Kramer PD. Listening to Prozac: A psychiatrist explores antidepressant drugs and the remaking of the self. New York: Penguin Books; 1994. 432 р.
- Khan A, Fahl Mar K, Gokul S, Brown WA. Decreased suicide rates in recent antidepressant clinical trials. Psychopharmacology (Berl). 2018;235(5):1455–1462.
- Brown GK, Jager-Hyman Sh. Evidence-based psychotherapies for suicide prevention future directions. Am J Prev Med. 2014;47(3S2):S186–S194.
- Cidik LI. Effektivnost’ antidepressantov v predotvrashchenii suicidov. Psihiatriya. Psihoterapiya i klinicheskaya psihologiya. Materialy konf., posv. 90-letiyu kafedry psihiatrii i med. psihologii Belorus. gos. med. un-ta. Minsk: Professional’nye izdaniya; 2015. р. 230–232.
- Moncrieff J. Psychiatric drug promotion and the politics of neoliberalism. British Journal of Psychiatry. 2006;195(3):301–302.
- Gainty C. From a “deranged” provocateur to IBM’s failed AI superproject: the controversial story of how data has transformed healthcare. The Conversation Published: January 16, 2023. https://theconversation.com/from-a-deranged-provocateur-to-ibms-failed-ai-superproject-the-controversial-story-of-how-data-has-transformed-healthcare-189362 (access date: 13.03.2023).
- Zorin NA. Apologiya industrial’noj modeli mediciny. Doklad na nauchno-prakticheskoj konferencii s mezhdunarodnym uchastiem “Status praesens psihiatrii. Mezhdisciplinarnyj konsilium”. Sankt-Peterburg, 29.11.1019. https://www.youtube.com/watch?v=wURXS6yo6_s (access date: 13.03.2023). (In Russ.)
- Zorin NA. Poisk chernoj koshki v temnoj komnate. O somnitel’noj cennosti poiska “ob”ektivnogo” diagnoza. Doklad na konferencii “Psihiatricheskie pokoleniya v poiske konsensusa” (Kazan’, 1 dekabrya 2021 goda). https://www.youtube.com/watch?v=f3iV0f991aM (access date: 13.03.2023). (In Russ.)
